SXTP expands ARAKODA label for babesiosis
A clinical development program targets expanding ARAKODA’s label from malaria into babesiosis, with an interim analysis in October and a potential early-2028 launch.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.